SOLIMANDO, ANTONIO GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 4.438
EU - Europa 1.329
AS - Asia 704
SA - Sud America 7
AF - Africa 5
OC - Oceania 2
Totale 6.485
Nazione #
US - Stati Uniti d'America 4.423
IT - Italia 433
SE - Svezia 390
CN - Cina 367
SG - Singapore 221
DE - Germania 145
FR - Francia 117
GB - Regno Unito 86
VN - Vietnam 42
FI - Finlandia 41
CZ - Repubblica Ceca 33
IN - India 30
BE - Belgio 28
KR - Corea 20
CA - Canada 13
UA - Ucraina 12
PL - Polonia 8
IE - Irlanda 7
EG - Egitto 5
ES - Italia 4
HK - Hong Kong 4
JP - Giappone 4
NL - Olanda 4
AT - Austria 3
CL - Cile 3
DK - Danimarca 3
IR - Iran 3
LT - Lituania 3
MY - Malesia 3
TR - Turchia 3
AU - Australia 2
CO - Colombia 2
HR - Croazia 2
HU - Ungheria 2
ID - Indonesia 2
AR - Argentina 1
BD - Bangladesh 1
BG - Bulgaria 1
BR - Brasile 1
CH - Svizzera 1
IL - Israele 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MX - Messico 1
NO - Norvegia 1
PA - Panama 1
PK - Pakistan 1
RO - Romania 1
RS - Serbia 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 6.485
Città #
Chandler 617
Fairfield 569
Ashburn 373
Nyköping 348
Woodbridge 303
Houston 243
Seattle 241
Cambridge 233
Ann Arbor 201
Singapore 171
Wilmington 169
New York 147
Bari 144
Dearborn 100
Lawrence 95
Roxbury 93
Marseille 83
Beijing 69
Des Moines 69
Nanjing 44
San Diego 44
Rome 42
Inglewood 40
Dong Ket 39
Boardman 37
Munich 35
Helsinki 33
Brooklyn 31
Brussels 28
Brno 26
Jacksonville 24
London 24
Los Angeles 23
Redwood City 23
Santa Clara 22
Paris 21
Washington 20
Princeton 19
Guangzhou 18
Leawood 16
Kunming 13
Pune 13
Shanghai 13
Shenyang 13
Grafing 12
Nanchang 11
Torrile 11
Hefei 10
Milan 10
Augusta 9
Hebei 9
Jinan 9
Jiaxing 8
Tianjin 8
Toronto 8
Brescia 7
Dublin 7
Wuhan 7
Frankfurt am Main 6
Mascalucia 6
Naples 6
Olomouc 6
Wuxi 6
Chicago 5
Nürnberg 5
Southwark 5
Kilburn 4
Norwalk 4
Palermo 4
Parma 4
Santa Marinella 4
St Albans 4
Taizhou 4
Tokyo 4
Triggiano 4
West Jordan 4
Zhengzhou 4
Changsha 3
Chengdu 3
Chiswick 3
Fuzhou 3
Graz 3
Grottaglie 3
Grumo Appula 3
Hanoi 3
Islington 3
Kuala Lumpur 3
Mumbai 3
Nagold 3
New Delhi 3
Ningbo 3
Obrigheim 3
Ottawa 3
San Mateo 3
Suri 3
Uljin County 3
Versailles 3
Vicenza 3
Acton 2
Amsterdam 2
Totale 5.211
Nome #
Adhesion-Mediated Multiple Myeloma (MM) Disease Progression: Junctional Adhesion Molecule a Enhances Angiogenesis and Multiple Myeloma Dissemination and Predicts Poor Survival 228
Central Function for JAM-a in Multiple Myeloma Patients with Extramedullary Disease. 147
Targeting B-cell non Hodgkin lymphoma: New and old tricks 134
Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients 132
The small subunit of Hemilipin2, a new heterodimeric phospholipase A2 from Hemiscorpius lepturus scorpion venom, mediates the antiangiogenic effect of the whole protein 127
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes 123
Microenvironment drug resistance in multiple myeloma: Emerging new players 120
JAM-A as a prognostic factor and new therapeutic target in multiple myeloma 120
JAM-A as a Prognostic Factor and New Therapeutic Target in Multiple Myeloma 120
B-Cell Therapies in Relapsing Remitting and Primary Progressive Multiple Sclerosis: A Short Clinical Review 117
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview 117
Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease 113
Suspected Pericardial Tuberculosis Revealed as an Amyloid Pericardial Mass 109
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment 108
Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma: A Pilot Study 108
Inhibition of focal adhesion kinase overcomes resistance of mantle cell lymphoma to ibrutinib in the bone marrow microenvironment 106
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma 101
CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer 99
Bone metastasis as primary presentation of pancreatic ductal adenocarcinoma: A case report and literature review 95
Dyspnea, Fatigue, and Generalized Weakness in a 67-Year-Old Man: Approach to the Patient Between Guidelines and Clinical Judgment 93
Emerging role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma 93
CIC Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAF‐MEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous System Involvement 92
Insights into the Regulation of Tumor Angiogenesis by Micro-RNAs 91
HB-EGF–EGFR Signaling in Bone Marrow Endothelial Cells Mediates Angiogenesis Associated with Multiple Myeloma 89
BL1391: an established cell line from a human malignant peripheral nerve sheath tumor with unique genomic features 87
Emerging Concepts in Acute Heart Failure: From the Pathophysiology to the Clinical Case Based Approach 87
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study 86
RAL GTPases mediate multiple myeloma cell survival and are activated independently of oncogenic RAS 86
Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma 86
A multiple myeloma that progressed as type i cryoglobulinemia with skin ulcers and foot necrosis: A case report 85
Long‐term survival of an advanced colorectal cancer patient treated with Regorafenib: Case report and literature review 82
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 80
null 77
CIC-Mutation As a Potential Molecular Mechanism of Acquired Resistance to Combined BRAF/MEK Inhibition in CNS Multiple Myeloma 76
Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib 75
Exploration of Artificial Intelligence Use with ARIES in Multiple Myeloma Research 73
Bortezomib treatment modulates autophagy in multiple myeloma 73
Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside 70
Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores the angiogenic homeostasis and suppresses tumor progression 67
Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma 66
Angiogenesis and Antiangiogenesis in Multiple Myeloma 60
Sonography of superficial lymph nodes in malignant lymphomas. Data from our case series. 59
A comprehensive biological and clinical perspective can drive a patient-tailored approach to multiple myeloma: Bridging the gaps between the plasma cell and the neoplastic niche 59
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department 58
Rituximab use in autoimmune diseases: a single center experience. 57
Antibiotic treatment in vasculitic leg ulcers: a single center experience 57
Actors on the scene: Immune cells in the myeloma niche 57
Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers? 56
null 55
Right Heart Changes Impact on Clinical Phenotype of Amyloid Cardiac Involvement: A Single Centre Study 55
Rituximab induces a reduction of lymphocyte CD3+ activated in patients with autoimmune diseases 54
Real-life experience with omalizumab in chronic spontaneous urticaria. 51
Bortezomib Treatment Modulates Autophagy in Multiple Myeloma 49
Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples 49
Immune system and bone microenvironment: rationale for targeted cancer therapies 48
Amyloid heart involvement lead a fast fatal evolution a healthy woman: a case report 48
Proangiogenic effect of bone marrow fibroblasts in patients with multiple myeloma 48
A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery 46
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma 46
Case Report: Lymphocytosis Associated With Fatal Hepatitis in a Thymoma Patient Treated With Anti-PD1: New Insight Into the Immune-Related Storm 46
Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection 46
Induction therapy and stem cell mobilization in patients with newly diagnosed multiple myeloma 44
The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment 43
Subcutaneous immunoglobulins in patients with multiple myeloma and secondary hypogammaglobulinemia: a randomized trial 41
Epstein–Barr Virus in Salivary Samples from Systemic Lupus Erythematosus Patients with Oral Lesions 41
Imaging evaluation of pulmonary and non-ischaemic cardiovascular manifestations of covid-19 40
null 39
Role of BRAF in Hepatocellular Carcinoma: A Rationale for Future Targeted Cancer Therapies 39
A HGF/cMET autocrine loop is operative in multiple myeloma bone marrow endothelial cells and may represent a novel therapeutic target 39
Antibiotics or No Antibiotics, That Is the Question: An Update on Efficient and Effective Use of Antibiotics in Dental Practice 39
null 38
Complete Response of Synchronous Liver Metastasis in a Pancreatic Ductal Adenocarcinoma: Could Surgery Represent a Therapeutic Option? 38
MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma Disease 38
Identification and monitoring of Copy Number Variants (CNV) in monoclonal gammopathy 38
Prognostic role of neoplastic markers in Takotsubo syndrome 37
Cytotoxic t-lymphocyte antigen-4 in colorectal cancer: Another therapeutic side of capecitabine 35
COVID-19 and the Endocrine System: A Comprehensive Review on the Theme 34
Fever, cough and breathlessness in a patient with digeorge syndrome 34
Cancer-Associated Angiogenesis: The Endothelial Cell as a Checkpoint for Immunological Patrolling 34
Myeloma cells regulate {miRNA} transfer from fibroblast-derived exosomes by expression of {lncRNAs} 34
null 33
Junctional adhesion molecule-A as a prognostic factor and new therapeutic target in multiple myeloma. 33
Angiogenesis as Therapeutic Target in Metastatic Prostate Cancer – Narrowing the Gap Between Bench and Bedside 33
circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in small cell lung cancer 32
null 32
null 31
An atypical presentation of intestinal neuroendocrine tumor. 31
The anti-vegf(R) drug discovery legacy: Improving attrition rates by breaking the vicious cycle of angiogenesis in cancer 31
Ricerca di base nello sviluppo di isatuximab e il suo impiego per il trattamento dei pazienti con mieloma multiplo recidivato/refrattario 30
The bone marrow niche landscape: a journey through aging, extrinsic and intrinsic stressors in the haemopoietic milieu 30
Telemedicine DSS-AI Multi Level Platform for Monoclonal Gammopathy Assistance 29
New insights in Diffuse Large B Cell Lymphoma Pathobiology 28
A Challenging Case of Visceral Leishmaniasis 27
Difference in growth hormone response to growth hormone-releasing hormone (GHRH) testing following GHRH subacute treatment in normal aging and growth hormone-deficient adults: Possible perspectives for therapeutic use of GHRH or its analogs in elderly subjects? 27
Second-line treatments for Advanced Hepatocellular Carcinoma: A Systematic Review and Bayesian Network Meta-analysis 27
Impact of Antigen Presentation Mechanisms on Immune Response in Autoimmune Hepatitis 26
Editorial: Angiogenesis blockade for the treatment of gastrointestinal cancer 25
Cardiovascular risk in patients with Takayasu arteritis directly correlates with diastolic dysfunction and inflammatory cell infiltration in the vessel wall: a clinical, ex vivo and in vitro analysis. 24
null 24
Thrombopoietin promotes angiogenesis and disease progression in patients with multiple myeloma 24
Totale 6.444
Categoria #
all - tutte 41.008
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.008


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020956 0 0 0 0 103 151 169 144 144 89 95 61
2020/20211.485 43 81 87 148 281 127 159 130 81 129 90 129
2021/2022941 79 36 30 33 40 84 38 50 76 82 135 258
2022/20231.584 158 225 129 126 150 176 43 187 287 26 53 24
2023/2024884 49 124 56 76 77 266 32 21 20 24 16 123
2024/2025621 151 60 175 133 102 0 0 0 0 0 0 0
Totale 7.159